Seacera Group Bhd is diversifying from property into the medical sector via the purchase of a stake in Proligen Sdn Bhd for the production of high grade blood filtration filters used in renal care.
It said on Tuesday it is buying a 51% stake or 520,000 shares at RM4.70 each in Proligen as it diversifies its revenue base in an area that is having less impact to building materials and will balance out the effect of the current economy downturn.
Following the purchase of the stake, Secera and the two shareholders of Proligen -- Zakaria Abdul Rashid and Andrew Suriady Sidekder – will jointly build and commission a new hollow-fibre polysulfone dialyzer filter plant.
For Free Signals and other KLSE online updates, click here OR Give A Missed Call : +60350219047 Follow Us On Twitter : www.twitter.com/epicresearchmy Like Us On Facebook : www.facebook.com/EpicResearchMalaysia Need Any Assistance Feel Free To Mail Us at : info@epicresearch.my
It said on Tuesday it is buying a 51% stake or 520,000 shares at RM4.70 each in Proligen as it diversifies its revenue base in an area that is having less impact to building materials and will balance out the effect of the current economy downturn.
Following the purchase of the stake, Secera and the two shareholders of Proligen -- Zakaria Abdul Rashid and Andrew Suriady Sidekder – will jointly build and commission a new hollow-fibre polysulfone dialyzer filter plant.
No comments:
Post a Comment